12/18/14 (Press Release)
NMS Labs and StopDUID.org Sponsor Update of 50 States DUI Law Compilation

12/2/14 (Press Release)
NMS Labs Selects RapidHIT® Platform to Deliver DNA Results in Record Time

10/1/14 (Press Release)
New Article highlights a more Effective Method for Analyzing Sexual Assault Evidence

9/16/14 (Press Release)
NMS Labs Announces Crucial New Tool for Impaired Driving Investigation

6/27/14 (Press Release)
NMS Labs Dr. Barry Logan Appointed to NIST Forensic Science Standards Board

6/26/14 (Press Release)
NMS Labs Launches Testing Solution to Detect Pyrrolidinophenones, a New Group of Designer Drugs

6/17/14 (Press Release)
NMS Labs Welcomes Jack Wright as Vice President of Sales and Marketing

6/12/14 (Press Release)
Robin Freeman is named the New General Manager of IFL

4/3/14 (Press Release)
NMS Labs Launches Testing Solution to Detect NBOMes, a Deadly Next Generation Designer Drug

2/4/14 (Press Release)
New Publication Highlights the Human Health Risks and Impairing Effects of Synthetic Cannabinoid Drugs

1/29/14 (Press Release)
NMS Labs Announces its Highly Specific Plasma Catecholamines Test by 2D-LC-MS/MS

11/26/13 (Press Release)
NMS Labs Statement on Yohe Decision – Right to Confrontation

11/20/13 (Press Release)
NMS Labs Appoints Pierre Cassigneul Chief Executive Officer

10/3/13 (Press Release)
NMS Labs Offers Genotype tests for Tramadol, Oxycodone and Codeine

9/11/13 (Press Release)
Cold Murder Case solutions group recognizes Dr. Rieders for decades of service to Vidocq Society and Forensic Science

8/1/13 (Press Release)
Dr. Barry Logan of NMS Labs Receives Prestigious International Award for Traffic Safety Research

7/30/13 (Press Release)
NMS Labs releases most recent designer drug trending data: 38% positivity rate reflects presence of emerging “Bath Salts”

6/28/13 (Press Release)
NMS Labs offers testing for acetyl fentanyl in response to CDC Health Advisory

3/27/13 (Press Release)
DesignerDrugTrends.org fills information void as nation’s first centralized resource for legislators, law enforcement and the medical community

2/19/13 (Press Release)
AAFS Recognizes Award-Winning Forensic Toxicologists of NMS Labs

12/4/12 (Press Release)
NMS Labs Proudly Welcomes Dr. Wenzhe Li as Senior Director of Clinical Services

8/21/12 (Press Release)
NMS Labs Announces Types and Amounts of Chemicals Used in Synthetic Marijuana Products Varies Widely, as Does Impact on Users

8/16/12 (Press Release)
NMS Labs launches highly comprehensive "bath salts" and designer stimulants testing to mirror designer drug trends on the street

7/18/12 (Press Release)
Clandestine Chemists Diversify to Stay Ahead of Latest Round of Drug Scheduling

6/5/12 (Press Release)
Pioneer of Postmortem Toxicology Joins NMS Labs

2/23/12 (Press Release)
NMS Labs launches updated legal blood alcohol test with Statement of Certainty™

2/14/12 (Press Release)
New Synthetic Drugs Circumvent DEA Scheduled Chemicals Found in Synthetic Cannabinoids

2/6/12 (In the News)
NMS Labs on the Growing Problem of Synthetic Drugs

9/20/11 (Press Release)
NMS Labs Unveils ELISA Assay for Synthetic Cannabinoids in Urine

8/30/11 (Press Release)
NMS Labs Expands its Synthetic Cannabinoids Lab Tests in Urine to Keep Pace with Changes in Compounds Found in “Fake Pot”

8/24/11 (Press Release)
NMS Labs Offers Testing Aligned with Pennsylvania’s Legislation Banning Synthetic Drugs Found in “Bath Salts”

8/16/11 (Press Release)
Award-Winning Forensic Toxicologist Dan Isenschmid Joins NMS Labs

8/3/11 (Press Release)
NMS Labs Announces Its New Chromium and Cobalt Test to Assist the Medical Community with Post Market Surveillance Studies on Metal Implant Exposure Cases

7/20/11 (Press Release)
Latest blood test detects 12 popular synthetic cannabinoids in “fake pot”

7/19/11 (Press Release)
NMS Labs & Draeger Safety Diagnostics Inc. Announce Commitment to Join Forces in Delivering Total Oral Fluid Drug Testing Solution for Law Enforcement

7/7/11 (Press Release)
NMS Labs announces identification of metabolite of additional synthetic cannabinoid, JWH-250

7/6/11 (Press Release)
NMS Labs Promotes Shelly H. Carolan to CMO and James G. Murphy to CFO--Two New Posts on its Executive Leadership Team

5/25/11 (Press Release)
NMS Labs & Cerilliant announce identification of major metabolite of the synthetic cannabinoid JWH-073

5/24/11 (Press Release)
NMS Labs Announces Identification of Major Metabolite of the Synthetic Cannabinoid JWH-018

4/12/11 (Press Release)
NMS Labs Dr. Barry Logan co-authors report that begins effort to assess drug impairment while driving

2/8/11 (Press Release)
NMS Labs Announces Its Highly Specific Methotrexate Lab Test, Helping Physicians to Improve Patient Care by Eliminating False Positive Results

2/1/11 (Press Release)
The Fredric Rieders Family Renaissance Foundation appoints Shelly H. Carolan, MBA to its Board of Directors

1/20/11 (Press Release)
NMS Labs Becomes One of the First American Laboratories to Earn the Prestigious ISO 15189 Accreditation from the College of American Pathologists

10/26/10 (Press Release)
The Fredric Rieders Family Renaissance Foundation Names New Director – Dr. Barry K. Logan Brings His World-Renowned Toxicological Expertise in Forensic Science Education and Detection of Drug Impaired Driving to the Organization

10/19/10 (Press Release)
Michael F. Rieders, PhD, Newly Appointed to Board of the National Association of Medical Examiners (The NAME) Foundation

10/13/10 (Press Release)
NMS Labs Identifies New Synthetic Marijuana in “Legal Everywhere” Incense Products K3 and K4

9/15/10 (Press Release)
NMS Labs Now Performs Urine Tests for Metabolites of Synthetic Cannabinoids Found in K2 and Spice

6/1/10 (Press Release)
Process improvement business leader Marlow Hicks newly appointed as Vice President of Operations at NMS Labs

5/18/10 (Press Release)
NMS Labs receives ISO 17025 via ASCLD/LAB-International accreditation

4/27/10 (Press Release)
Phthalate Metabolites Developed and Offered at NMS Labs as a Follow Up to Its Groundbreaking Bisphenol-A Urine Test

3/30/10 (Press Release)
NMS Labs launches pain management lab test for Milnacipran, a new drug approved by the FDA for the treatment of Fibromyalgia pain

3/3/10 (Press Release)
NMS Labs named Best Employer for New Graduates by phillyBurbs.com’s Job Trends Best Places to Work 2010

1/26/10 (Press Release)
NMS Labs Responds to National Health Concerns with Its Groundbreaking Test to Monitor Bisphenol-A (BPA) Levels in Humans

1/19/10 (Press Release)
NMS Labs Stands Up to Skyrocketing Healthcare Costs, Suspending Annual Across-the-Board Price Increase in 2010 for Esoteric Lab Tests

1/19/10 (Press Release)
NMS Labs Offers Law Enforcement Officials a Powerful Tool to Assist with Enforcing the Ban Of Salvinorin A & B

1/19/10 (Press Release)
NMS Labs Suspends An Across-The-Board Price Increase Of Its Forensic Testing In An Effort To Assist With Public Budget Deficit Issues

9/8/09 (Press Release)
NMS Labs Director of Forensic Services reports driving impairment and DUI arrests following abuse of cold medications

8/7/09 (Press Release)
Supporting the 12-step DRE protocol with forensic toxicology services designed with the oversight of Dr. Barry K. Logan

6/2/09 (Press Release)
NMS Labs Clinical Director of Endocrinology publishes groundbreaking research that compares measurement techniques for free thyroid hormones

2/24/09 (Press Release)
Collaboration is key as NMS Labs introduces its wiki

2/18/09 (Press Release)
Build or buy? Making sense of tighter budgets

2/10/09 (Press Release)
Thought leader joins NMS Labs as its Clinical Director of Endocrinology

12/4/08 (Press Release)
Neatly bundled and tightly bound . . . Three levels of lab testing available to the postmortem industry

11/18/08 (Press Release)
NMS Labs provides endocrinologists with better diagnostic insights and patient care through tandem mass spectrometry (LC-MS/MS)

8/11/08 (Press Release)
Dr. Barry K. Logan Joins NMS Labs As Director Of Toxicological Services Bringing His World-Renowned Expertise In Alcohol And Drug Impaired Driving